Time course of response to paroxetine: Influence of plasma level
Authors:
- Marianne Gex-FabryMGMarianne Gex-Fabry
- Nicola GervasoniNGNicola Gervasoni
- Chin B. EapCEChin B. Eap
- Jean-Michel AubryJAJean-Michel Aubry
- Guido BondolfiGBGuido Bondolfi
- Gilles BertschyGBGilles Bertschy
- 1 May 2007
- journal article
- clinical trial
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 31 (4) , 892-900
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Paroxetine: population pharmacokinetic analysis in late‐life depression using sparse concentration samplingBritish Journal of Clinical Pharmacology, 2006
- Late-onset major depression: clinical and treatment-response variabilityInternational Journal of Geriatric Psychiatry, 2005
- The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in PsychiatryPharmacopsychiatry, 2004
- Effectiveness of pindolol plus serotonin uptake inhibitors in depression: a meta-analysis of early and late outcomes from randomised controlled trialsJournal of Affective Disorders, 2004
- The pharmacology of putative early-onset antidepressant strategiesEuropean Neuropsychopharmacology, 2003
- Does increasing dose improve efficacyin patients with poor antidepressantresponse: a reviewActa Psychiatrica Scandinavica, 2000
- Is Therapeutic Drug Monitoring a Case for Optimizing Clinical Outcome and Avoiding Interactions of the Selective Serotonin Reuptake Inhibitors?Therapeutic Drug Monitoring, 2000
- Simultaneous Determination of Human Plasma Levels of Citalopram, Paroxetine, Sertraline, and Their Metabolites by Gas Chromatography--Mass SpectrometryJournal of Chromatographic Science, 1998
- ParoxetineDrugs, 1991
- Paroxetine: A selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter studyJournal of Affective Disorders, 1990